Medicina
Glycemic Outcomes After Switching from SGLT2 Inhibitors to DPP-4 Inhibitors in Type 2 Diabetes, with a Comparison of Teneligliptin and Other Agents: A Retrospective Cohort Study
Study in peopleInterventions
Clinical Pharmacology and Therapeutics4 Oct 2026
Diabetes & Vascular Disease Research4 Oct 2026
Clinical Journal of the American Society of Nephrology4 Oct 2026
Diabetes, Obesity & Metabolism4 Oct 2026